University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Myotube growth is associated with cancer-like metabolic reprogramming and is limited by phosphoglycerate dehydrogenase

Simple item page
dc.contributor.authorStadhouders, Lian E.M.
dc.contributor.authorSmith, Jonathon A.B.
dc.contributor.authorGabriel, Brendan M.
dc.contributor.authorVerbrugge, Sander A.J.
dc.contributor.authorHammersen, Tim D.
dc.contributor.authorKolijn, Detmar
dc.contributor.authorVogel, Ilse S.P.
dc.contributor.authorMohamed, Abdalla D.
dc.contributor.authorde Wit, Gerard M.J.
dc.contributor.authorOffringa, Carla
dc.contributor.authorHoogaars, Willem M.H.
dc.contributor.authorGehlert, Sebastian
dc.contributor.authorWackerhage, Henning
dc.contributor.authorJaspers, Richard T.
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Cardiovascular and Diabetes Centreen
dc.date.accessioned2023-12-14T14:44:00Z
dc.date.available2023-12-14T14:44:00Z
dc.date.issued2023-12-15
dc.descriptionFunding Information: Brendan M. Gabriel was supported by fellowships from the Novo Nordisk Foundation ( NNF19OC0055072 ) & the Wenner-Gren Foundation , an Albert Renold Travel Fellowship from the European Foundation for the Study of Diabetes , and an Eric Reid Fund for Methodology from the Biochemical Society . Abdalla D. Mohamed was funded initially by Sarcoma UK (grant number SUK09.2015 ), then supported by funding from Postdoctoral Fellowship Program ( Helmholtz Zentrum München, Germany ), and currently by Cancer Research UK . Publisher Copyright: © 2023 The Authorsen
dc.description.statusPeer revieweden
dc.format.extent11426458
dc.identifier282666004
dc.identifierf40d2bbc-33a1-46be-9aed-1d35608f9730
dc.identifier85175096892
dc.identifier37879549
dc.identifier.citationStadhouders, L E M, Smith, J A B, Gabriel, B M, Verbrugge, S A J, Hammersen, T D, Kolijn, D, Vogel, I S P, Mohamed, A D, de Wit, G M J, Offringa, C, Hoogaars, W M H, Gehlert, S, Wackerhage, H & Jaspers, R T 2023, 'Myotube growth is associated with cancer-like metabolic reprogramming and is limited by phosphoglycerate dehydrogenase', Experimental Cell Research, vol. 433, no. 2, 113820. https://doi.org/10.1016/j.yexcr.2023.113820en
dc.identifier.doi10.1016/j.yexcr.2023.113820
dc.identifier.iss2en
dc.identifier.issn0014-4827
dc.identifier.otherORCID: /0000-0001-6878-8779/work/148966757
dc.identifier.urihttps://hdl.handle.net/2164/22420
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85175096892&partnerID=8YFLogxKen
dc.identifier.vol433en
dc.language.isoeng
dc.relation.ispartofExperimental Cell Researchen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectGlycolysisen
dc.subjectHypertrophyen
dc.subjectInsulin-like growth factor Ien
dc.subjectMetabolismen
dc.subjectSkeletal muscleen
dc.subjectWarburg effecten
dc.subjectCell Biologyen
dc.titleMyotube growth is associated with cancer-like metabolic reprogramming and is limited by phosphoglycerate dehydrogenaseen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Stadhouders_Etal_ECR_Myotube_Growth_Is_VOR.pdf
Size:
10.9 MB
Format:
Adobe Portable Document Format
Download

Collections

All research